As of 2026-05-04, the Relative Valuation of Mirum Pharmaceuticals Inc (MIRM) is (7.51) USD. This relative valuation is based on P/E multiples. With the latest stock price at 96.53 USD, the upside of Mirum Pharmaceuticals Inc based on Relative Valuation is -107.8%.
The range of the Relative Valuation is (6.81) - (7.71) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.6x - 21.4x | 19.2x |
| Forward P/E multiples | 16.8x - 19.9x | 19.6x |
| Fair Price | (6.81) - (7.71) | (7.51) |
| Upside | -107.1% - -108.0% | -107.8% |
| Date | P/E |
| 2026-04-30 | -251.32 |
| 2026-04-29 | -243.29 |
| 2026-04-28 | -242.78 |
| 2026-04-27 | -238.85 |
| 2026-04-24 | -236.29 |
| 2026-04-23 | -237.48 |
| 2026-04-22 | -243.58 |
| 2026-04-21 | -241.04 |
| 2026-04-20 | -247.19 |
| 2026-04-17 | -252.98 |
| 2026-04-16 | -247.58 |
| 2026-04-15 | -248.97 |
| 2026-04-14 | -250.27 |
| 2026-04-13 | -249.21 |
| 2026-04-10 | -245.87 |
| 2026-04-09 | -255.56 |
| 2026-04-08 | -252.98 |
| 2026-04-07 | -247.04 |
| 2026-04-06 | -248.56 |
| 2026-04-02 | -243.21 |
| 2026-04-01 | -244.38 |
| 2026-03-31 | -238.59 |
| 2026-03-30 | -227.02 |
| 2026-03-27 | -228.42 |
| 2026-03-26 | -229.55 |
| 2026-03-25 | -232.88 |
| 2026-03-24 | -226.97 |
| 2026-03-23 | -230.97 |
| 2026-03-20 | -228.60 |
| 2026-03-19 | -234.30 |
| 2026-03-18 | -236.73 |
| 2026-03-17 | -249.36 |
| 2026-03-16 | -239.26 |
| 2026-03-13 | -234.15 |
| 2026-03-12 | -231.88 |
| 2026-03-11 | -236.96 |
| 2026-03-10 | -234.85 |
| 2026-03-09 | -229.29 |
| 2026-03-06 | -222.89 |
| 2026-03-05 | -226.87 |
| 2026-03-04 | -240.30 |
| 2026-03-03 | -226.76 |
| 2026-03-02 | -232.68 |
| 2026-02-27 | -238.36 |
| 2026-02-26 | -238.10 |
| 2026-02-25 | -280.53 |
| 2026-02-24 | -277.59 |
| 2026-02-23 | -273.48 |
| 2026-02-20 | -271.60 |
| 2026-02-19 | -272.45 |